What is the Markets View on Theseus Pharmaceuticals Inc Stocks Price and Volume Trends Wednesday - InvestorsObserver
THRXDelisted Stock | USD 3.71 0.14 3.92% |
Slightly above 55% of Theseus Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Theseus Pharmaceuticals suggests that some traders are interested regarding Theseus Pharmaceuticals' prospects. Theseus Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Theseus Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Theseus |
What is the Markets View on Theseus Pharmaceuticals Inc Stocks Price and Volume Trends Wednesday InvestorsObserver
Read at news.google.com
Theseus Pharmaceuticals Fundamental Analysis
We analyze Theseus Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theseus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theseus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Theseus Pharmaceuticals is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Theseus Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theseus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Theseus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Theseus Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Theseus Pharmaceuticals Related Equities
ERAS | Erasca | 7.57 | ||||
ELVN | Enliven Therapeutics | 6.22 | ||||
IPSC | Century Therapeutics | 2.97 | ||||
XFOR | X4 Pharmaceuticals | 2.74 | ||||
TERN | Terns Pharmaceuticals | 2.35 | ||||
CGEM | Cullinan Oncology | 1.72 | ||||
PMVP | Pmv Pharmaceuticals | 1.32 | ||||
MRSN | Mersana Therapeutics | 0.70 | ||||
IMRX | Immuneering Corp | 0.45 | ||||
DAWN | Day One | 0.32 | ||||
BPMC | Blueprint Medicines | 0.02 | ||||
RCUS | Arcus Biosciences | 0.13 | ||||
GLUE | Monte Rosa | 1.14 | ||||
DSGN | Design Therapeutics | 1.28 | ||||
RLAY | Relay Therapeutics | 1.44 | ||||
HOOK | Hookipa Pharma | 2.99 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |